1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. ABBOTT INDIA LTD.

Abbott India Ltd.

NSE: ABBOTINDIA | BSE: 500488

Expensive Performer
Download real time

31180.00 575.00 (1.88%)

Near 52W High of ₹31898.95

9,752 NSE+BSE Volume

NSE 03 Jun, 2025 2:18 PM (IST)

Watchlist

Portfolio

Alert

Share
21S
7W
7O
2T
66,255.3

Market Cap

High in industry
46.8

PE TTM

Above industry Median
2.6

PEG TTM

PEG TTM is much higher than 1
15.7

Price to Book

High in industry
0.4

Beta 1Year

Very Low volatility


Board Meetings - Abbott India Ltd.

The latest board meeting for Abbott India Ltd. took place on 15 May 2025, for the purpose of Audited Results & Final Dividend

Share
Ex-date Purpose Notes
15 May 2025 Audited Results & Final Dividend -
05 Feb 2025 Quarterly Results -
07 Nov 2024 Quarterly Results -
07 Aug 2024 Quarterly Results -
09 May 2024 Audited Results & Final Dividend -
01 Feb 2024 Quarterly Results -
09 Nov 2023 Quarterly Results -
09 Aug 2023 Quarterly Results -
19 May 2023 Audited Results & Final Dividend -
10 Feb 2023 Quarterly Results -
14 Nov 2022 Quarterly Results -
10 Aug 2022 Quarterly Results -
17 May 2022 Audited Results & Dividend -
09 Feb 2022 Quarterly Results -
12 Nov 2021 Quarterly Results -
06 Aug 2021 Quarterly Results -
18 May 2021 Audited Results & Final Dividend -
09 Feb 2021 Quarterly Results -
11 Nov 2020 Quarterly Results -
07 Aug 2020 Quarterly Results -
08 Jun 2020 Audited Results & Dividend -
07 Feb 2020 Quarterly Results -
12 Nov 2019 Quarterly Results -
08 Aug 2019 Quarterly Results -
27 May 2019 Audited Results & Dividend -
08 Feb 2019 Quarterly Results -
13 Nov 2018 Quarterly Results -
13 Aug 2018 Quarterly Results -
14 May 2018 Audited Results & Dividend -
14 Feb 2018 Quarterly Results -
13 Nov 2017 Quarterly Results -
08 Aug 2017 Quarterly Results -
19 May 2017 Audited Results & Final Dividend -
06 Feb 2017 Quarterly Results -
28 Nov 2016 Quarterly Results -
22 Nov 2016 Resignation of the Company Secretary -
26 Aug 2016 Quarterly Results -
25 May 2016 Audited Results & Final Dividend Appointment of new Registrar and Share Transfer Agent.
01 Feb 2016 Quarterly Results -
06 Nov 2015 Quarterly Results -
12 Aug 2015 Quarterly Results -
27 May 2015 Audited Results & Final Dividend -
10 Feb 2015 Quarterly Results -
11 Nov 2014 Quarterly Results -
28 May 2014 Audited Results & Final Dividend Revised from 27/05/2014
08 Feb 2014 Quarterly Results -
14 Aug 2013 Quarterly Results -
03 Jun 2013 Others To consider the sale and transfer of, or other appropriate restructuring of, the proprietary pharmaceuticals dIvision ("PPD") of the Company.
25 Apr 2013 Quarterly Results -
20 Feb 2013 Audited Results & Final Dividend -
10 Nov 2012 Quarterly Results -
03 Aug 2012 Quarterly Results -
14 May 2012 Quarterly Results -
15 Mar 2012 Appointment / Resignation of M.D The Board has appointed Mr. Rehan Khan as Managing Director of the Company w.e.f May 15, 2012 & accepted the resignation of Mr. Vivek Mohan as Managing Director of the Company w.e.f May 15, 2012.
28 Feb 2012 Audited Results & Final Dividend The Board has recommended a Final Dividend of Rs. 17.00 per Equity Share of the face value Rs. 10 on 2,12,49,302 Equity Shares of the Company.
01 Nov 2011 Quarterly Results -
11 Aug 2011 Quarterly Results -
27 Apr 2011 Quarterly Results -
28 Feb 2011 Audited Results & Final Dividend -
21 Dec 2010 Quarterly Results -
24 Nov 2010 To consider a proposal for Merger To consider a proposal for Merger of Solvay Pharma India Ltd. with the Company in terms of the provisions of Sections 391 to 394 of the Companies Act, 1956.
28 Sep 2010 Quarterly Results -
29 Jun 2010 Quarterly Results & Others To change the accounting year of the Co. from Dec 01 - Nov 30 to the calendar year Jan 01 - Dec 31 therefore, The statutory books of accounts of the Co. prepared for a period of 13 months.
30 Mar 2010 Quarterly Results -
01 Feb 2010 Audited Results & Dividend -
29 Sep 2009 Quarterly Results -
24 Jun 2009 Quarterly Results -
30 Mar 2009 Quarterly Results -
28 Jan 2009 Audited Results & Dividend -
23 Sep 2008 Quarterly Results -
20 Jun 2008 Quarterly Results -
28 Mar 2008 Quarterly Results -
14 Feb 2008 Audited Results & Dividend -
30 Sep 2007 Quarterly Results (Revised)
05 Sep 2007 Buy Back of Shares To consider a proposal for buyback of a portion of fully paid equity shares of the Company at a price to be determined by the Board, which will not exceed Rs 650/- per equity share.
21 Jun 2007 Quarterly Results -
08 Feb 2007 Accounts & Dividend -
18 Sep 2006 Quarterly Results -
25 Aug 2006 Buy Back of Shares -
29 Jun 2006 Quarterly Results -
31 Mar 2006 Quarterly Results -
07 Mar 2006 Accounts & Dividend (Revised)
21 Sep 2005 Quarterly Results -
28 Jun 2005 Quarterly Results -
22 Mar 2005 Quarterly Results -
25 Jan 2005 Accounts & Dividend -
28 Sep 2004 Quarterly Results -
28 Jun 2004 Quarterly Results -
24 Mar 2004 Quarterly Results -
25 Feb 2004 Accounts & Dividend -
24 Oct 2003 Quarterly Results & Others Amalgamation of Lenbrook Pharmaceuticals with the Company.
30 Sep 2003 Quarterly Results -
18 Jun 2003 Quarterly Results -
31 Mar 2003 Quarterly Results -
21 Feb 2003 Dividend & Accounts -
25 Sep 2002 Quarterly Results -
27 Jun 2002 Quarterly Results -
27 Mar 2002 Quarterly Results -
27 Feb 2002 Accounts, Dividend(11 months) & Others Accounts & Dividend(11 months)and buy back of equity shares and Sale of company's undertaking at E-1, MIDC Industrial Area, Jejuri 412303.
23 Oct 2001 Quarterly Results -